Verve Therapeutics Statistics

Total Valuation

TSX:CCM has a market cap or net worth of CAD 85.59 million. The enterprise value is 82.80 million.

Market Cap	85.59M
Enterprise Value	82.80M

Important Dates

The next estimated earnings date is Monday, August 11, 2025.

Earnings Date	Aug 11, 2025
Ex-Dividend Date	n/a

Share Statistics

TSX:CCM has 184.06 million shares outstanding. The number of shares has increased by 15.69% in one year.

Current Share Class	184.06M
Shares Outstanding	184.06M
Shares Change (YoY)	+15.69%
Shares Change (QoQ)	+1.58%
Owned by Insiders (%)	0.41%
Owned by Institutions (%)	2.13%
Float	94.66M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
PB Ratio	1.88
P/TBV Ratio	1.88
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-39.03
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-9.37

Financial Position

The company has a current ratio of 2.05, with a Debt / Equity ratio of 0.00.

Current Ratio	2.05
Quick Ratio	2.05
Debt / Equity	0.00
Debt / EBITDA	n/a
Debt / FCF	-0.02
Interest Coverage	-130.18

Financial Efficiency

Return on equity (ROE) is -4.57% and return on invested capital (ROIC) is -2.76%.

Return on Equity (ROE)	-4.57%
Return on Assets (ROA)	-2.56%
Return on Invested Capital (ROIC)	-2.76%
Return on Capital Employed (ROCE)	-4.26%
Revenue Per Employee	n/a
Profits Per Employee	-530,382
Employee Count	4
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	-389,522
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +60.35% in the last 52 weeks. The beta is 0.11, so TSX:CCM's price volatility has been lower than the market average.

Beta (5Y)	0.11
52-Week Price Change	+60.35%
50-Day Moving Average	0.39
200-Day Moving Average	0.34
Relative Strength Index (RSI)	63.95
Average Volume (20 Days)	54,284

Short Selling Information

The latest short interest is 9,373, so 0.01% of the outstanding shares have been sold short.

Short Interest	9,373
Short Previous Month	220
Short % of Shares Out	0.01%
Short % of Float	0.01%
Short Ratio (days to cover)	n/a

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-2.06M
Pretax Income	-2.51M
Net Income	-2.12M
EBITDA	-2.04M
EBIT	-2.06M
Earnings Per Share (EPS)	-0.01

Full Income Statement

Balance Sheet

The company has 2.98 million in cash and 196,917 in debt, giving a net cash position of 2.79 million or 0.02 per share.

Cash & Cash Equivalents	2.98M
Total Debt	196,917
Net Cash	2.79M
Net Cash Per Share	0.02
Equity (Book Value)	45.65M
Book Value Per Share	0.25
Working Capital	1.63M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -274,534 and capital expenditures -8.57 million, giving a free cash flow of -8.84 million.

Operating Cash Flow	-274,534
Capital Expenditures	-8.57M
Free Cash Flow	-8.84M
FCF Per Share	-0.05

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

TSX:CCM does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-15.69%
Shareholder Yield	n/a
Earnings Yield	-2.48%
FCF Yield	-10.33%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on December 8, 2020. It was a reverse split with a ratio of 0.2.

Last Split Date	Dec 8, 2020
Split Type	Reverse
Split Ratio	0.2

Scores

Altman Z-Score	n/a
Piotroski F-Score	1